Equillium Inc a clinicalstage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders and Biocon Ltd an innovationled global biopharmaceuticals company today announced that they have expanded their collaboration a...

Iktos a company specialized in Artificial Intelligence for novel drug design and Almirall SA ALM a leading skinhealth focused global pharmaceutical company today announced a collaboration agreement in Artificial Intelligence AI where Iktos generative modelling technology will be used to design novel...

Forendo Pharma a clinical stage drug development company focusing on novel treatments in womens health today announces signing of a License and Collaboration Agreement with Novartis The joint research collaboration is aimed at the identification of novel drugs for the treatment of chronic liver dise...

NeoImmuneTech Inc a clinicalstage T cellfocused biopharmaceutical company announced today it has entered into a clinical collaboration agreement with Merck known as MSD outside of the United States and Canada through a subsidiary to evaluate the combination of NeoImmuneTechs Hyleukin NTI and Mercks...

Bloom Science a biopharmaceutical company developing microbiomederived therapeutics in multiple neurological conditions and oncology today announced the launch of a research agreement with CedarsSinai Medical Center The collaboration will focus on advancing the understanding of the microbiome in a P...

Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform and Morphic Therapeutic Morphic a biopharmaceutical company developing oral integrin therapies today announce that they have en...

Samyang Biopharm USA Inc a global biotech subsidiary of the Samyang Pharmaceuticals Corp announced today that the company has entered into a research collaboration with the exclusive option to a worldwide licensing agreement with Talix Therapeutics NV Financial terms of the agreement were not disclo...

Avitide Inc the industry leader in the discovery and development of custom affinity purification resins announces that it has entered into an exclusive license agreement to support the development of one of Gemini Therapeutics therapeutic programs

Janssen Biotech Inc a Janssen Pharmaceutical Company of Johnson Johnson announced today that it has entered a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc Bermekimab is an antiILalpha monoclonal antibody mAb in Phase development for the tr...

The US Food and Drug Administration today granted accelerated approval to Vyondys golodirsen injection to treat Duchenne muscular dystrophy DMD patients who have a confirmed mutation of the dystrophin gene that is amenable to exon skipping It is estimated that about percent of patients with DMD h...

Pfizer Inc announced today that the US Food and Drug Administration FDA has approved XELJANZ XR tofacitinib extendedrelease mg and mg tablets for the oncedaily treatment of adult patients with moderately to severely active ulcerative colitis UC after an inadequate response or intolerance to TNF bl...

ZETA is providing the detailed layout for the singleuse plant in which upstream midstream and downstream processes are integrated in a single module The complex multipurpose plant is designed for the utmost flexibility to map a wide range of processes at different scales

Worlds largest halal trade fair the Malaysia International Halal Showcase MIHAS is set to host Malaysian and global Halalbased businesses at its th edition from to April In this edition MIHAS will be facilitating the promotion of sustainability practices among Halalbased industry players

Kite a Gilead Company and Kiniksa Pharmaceuticals Ltd announced today that the companies have entered into a clinical collaboration to conduct a Phase multicenter study of mavrilimumab an investigational fully human monoclonal antibody that targets granulocyte macrophage colony stimulating factor r...

Novartis today announced that the US Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA for Xolair omalizumab for the treatment of nasal polyps in adult patients years of age and older with inadequate response to intranasal corticosteroids If...

Zealand Pharma AS a Copenhagenbased biotechnology company focused on the discovery and development of innovative peptidebased medicines announces that partner Beta Bionics Inc has received Breakthrough Device designation from the US Food and Drug Administration FDA for its iLet Bionic Pancreas Syst...

Dermira Inc a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions today announced that the US Food and Drug Administration FDA has granted Fast Track design...

According to studies an evergreater number of staff members are complaining about increasing mental stress Nevertheless according to a recent survey among staff members commissioned by LinkedIn percent of employers do not offer any preventive actions for stress symptoms such as tension or sleep dis...